bioMérieux S.A.
BMXMF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.95B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $11.95 Billion |
|---|---|
| Enterprise Value | $11.72 Billion |
| Annual dividend | $1.13 |
| Dividend yield | 1.05% |
| Earnings per Share | $3.37 |
| Beta | 0.59 |
| Outstanding Shares | 117,760,000 |
Return
| Return on Equity | 19.51% |
|---|---|
| Return on Assets | 14.73% |
| Return on Invested Capital | 24.93% |
Valuation & Multiples
| P/E Ratio | 23.74 |
|---|---|
| PEG | 58.71 |
| Price to Sales | 1.5 |
| Price to Book Ratio | 2.84 |
| Enterprise Value to Revenue | 1.45 |
| Enterprise Value to EBIT | 10.29 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 28, 2026
EPS
$2.27
Est. $2.32Revenue
$2.24 B
Est. $2.21 BNext Earnings Call
Expected Date
February 26, 2027
EPS Estimate
$2.81
Consensus analyst estimateRevenue Estimate
$2.44 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About bioMérieux S.A.
14,894 employees
CEO: Pierre Boulud
bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems...